微生物API市場-規模、シェア、動向分析レポート、およびセグメント予測、2023〜2030

レポートナンバー　0000036731

医薬品原料・製剤

微生物API市場-規模、シェア、動向分析レポート、およびセグメント予測、2023〜2030

Grand View Research Inc.

Microbial API Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2023- 2030

発刊日 2023/11

言語英語

体裁PDF/180ページ

ライセンス/価格180ページ

0000036731

Individual	5,950USD
Team	6,950USD
Enterprise	8,950USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

お問い合わせ

サンプル依頼

無料サンプル

サンプルはお問い合わせください。

レポート概要

微生物API市場規模、シェア、動向分析レポート（ホース別（哺乳類、細菌、真菌）、タイプ別（抗体、ペプチド、タンパク質）、サイト別、分子別、エンドユース別、地域別、およびセグメント予測、2023〜 2030

微生物APIの市場規模と動向

世界の微生物APIの市場規模は2022年に580億4,000万ドルと推定され、2023年から2030年にかけて6.66%のCAGRで成長すると予想されます。市場の成長を促す要因は、生物学的医薬品の需要の高まりと、発酵プロセスを使用した開発の容易さにあります。発酵は通常、微生物や細菌によって行われ、発生条件を大幅に変更することで窒素と炭素を非常に価値のある微生物の API や中間体に変換し、二次代謝産物の生成を助けます。このプロセスによってもたらされる容易さと費用対効果が、市場全体の成長を推進しています。

レポート詳細

Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Increasing prevalence of chronic conditions
3.4.2. Increased demand for biological products, amino acids, and antibiotics
3.4.3. Increasing investment in the pharmaceutical industry
3.4.4. Advances in molecular biology and synthetic biology
3.5. Market Restraint Analysis
3.5.1. High cost associated with the procedure
3.6. Penetration and Growth Prospect Mapping 2022
3.7. Business Environment Analysis
3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.7.2. Porter’s Five Forces Analysis

Chapter 4. Host Business Analysis
4.1. Microbial API Market: Host Movement Analysis
4.2. Mammalian
4.2.1. Mammalian Market, 2018 - 2030 (USD Million)
4.3. Bacterial
4.3.1. Bacterial Market, 2018 - 2030 (USD Million)
4.4. Fungal
4.4.1. Fungal Market, 2018 - 2030 (USD Million)

Chapter 5. Type Business Analysis
5.1. Microbial API Market: Type Movement Analysis
5.2. Antibody
5.2.1. Antibody Market, 2018 - 2030 (USD Million)
5.3. Peptide
5.3.1. Peptide Market, 2018 - 2030 (USD Million)
5.4. Protein
5.4.1. Protein Market, 2018 - 2030 (USD Million)
5.5. Small Molecule
5.5.1. Small Molecule Market, 2018 - 2030 (USD Million)
5.6. Vaccine
5.6.1. Vaccine Market, 2018 - 2030 (USD Million)

Chapter 6. Site Business Analysis
6.1. Microbial API Market: Site Movement Analysis
6.2. In-house
6.2.1. In-house Market, 2018 - 2030 (USD Million)
6.3. Outsourced
6.3.1. Outsourced Market, 2018 - 2030 (USD Million)

Chapter 7. End-use Business Analysis
7.1. Microbial API Market: End-use Movement Analysis
7.2. Pharmaceutical Companies
7.2.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
7.3. Biopharmaceutical Companies
7.3.1. Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
7.4. Others
7.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Molecule Business Analysis
8.1. Microbial API Market: Molecule Movement Analysis
8.2. Innovative
8.2.1. Innovative Market, 2018 - 2030 (USD Million)
8.3. Generic
8.3.1. Generic Market, 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis
9.1. Microbial API Market Share By Region, 2022 & 2030
9.2. North America
9.2.1. SWOT Analysis
9.2.2. North America Microbial API Market, 2018 - 2030 (USD Million)
9.2.3. U.S.
9.2.3.1. Key Country Dynamics
9.2.3.2. Target Disease Prevalence
9.2.3.3. Competitive Scenario
9.2.3.4. Regulatory Framework
9.2.3.5. Reimbursement Scenario
9.2.3.6. U.S. Microbial API Market, 2018 - 2030 (USD MILLION)
9.2.4. Canada
9.2.4.1. Key Country Dynamics
9.2.4.2. Target Disease Prevalence
9.2.4.3. Competitive Scenario
9.2.4.4. Regulatory Framework
9.2.4.5. Reimbursement Scenario
9.2.4.6. Canada Microbial API Market, 2018 - 2030 (USD Million)
9.3. Europe
9.3.1. SWOT Analysis
9.3.2. Europe Microbial API Market, 2018 - 2030 (USD Million)
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Target Disease Prevalence
9.3.3.3. Competitive Scenario
9.3.3.4. Regulatory Framework
9.3.3.5. Reimbursement Scenario
9.3.3.6. Germany Microbial API Market, 2018 - 2030 (USD Million)
9.3.4. UK
9.3.4.1. Key Country Dynamics
9.3.4.2. Target Disease Prevalence
9.3.4.3. Competitive Scenario
9.3.4.4. Regulatory Framework
9.3.4.5. Reimbursement Scenario
9.3.4.6. UK Microbial API Market, 2018 - 2030 (USD Million)
9.3.5. France
9.3.5.1. Key Country Dynamics
9.3.5.2. Target Disease Prevalence
9.3.5.3. Competitive Scenario
9.3.5.4. Regulatory Framework
9.3.5.5. Reimbursement Scenario
9.3.5.6. France Microbial API Market, 2018 - 2030 (USD Million)
9.3.6. Italy
9.3.6.1. Key Country Dynamics
9.3.6.2. Target Disease Prevalence
9.3.6.3. Competitive Scenario
9.3.6.4. Regulatory Framework
9.3.6.5. Reimbursement Scenario
9.3.6.6. Italy Microbial API Market, 2018 - 2030 (USD Million)
9.3.7. Spain
9.3.7.1. Key Country Dynamics
9.3.7.2. Target Disease Prevalence
9.3.7.3. Competitive Scenario
9.3.7.4. Regulatory Framework
9.3.7.5. Reimbursement Scenario
9.3.7.6. Spain Microbial API Market, 2018 - 2030 (USD Million)
9.3.8. Denmark
9.3.8.1. Key Country Dynamics
9.3.8.2. Target Disease Prevalence
9.3.8.3. Competitive Scenario
9.3.8.4. Regulatory Framework
9.3.8.5. Reimbursement Scenario
9.3.8.6. Denmark Microbial API Market, 2018 - 2030 (USD Million)
9.3.9. Sweden
9.3.9.1. Key Country Dynamics
9.3.9.2. Target Disease Prevalence
9.3.9.3. Competitive Scenario
9.3.9.4. Regulatory Framework
9.3.9.5. Reimbursement Scenario
9.3.9.6. Sweden Microbial API Market, 2018 - 2030 (USD Million)
9.3.10. Norway
9.3.10.1. Key Country Dynamics
9.3.10.2. Target Disease Prevalence
9.3.10.3. Competitive Scenario
9.3.10.4. Regulatory Framework
9.3.10.5. Reimbursement Scenario
9.3.10.6. Norway Microbial API Market, 2018 - 2030 (USD Million)
9.4. Asia Pacific
9.4.1. SWOT Analysis
9.4.2. Asia Pacific Microbial API Market, 2018 - 2030 (USD Million)
9.4.3. Japan
9.4.3.1. Key Country Dynamics
9.4.3.2. Target Disease Prevalence
9.4.3.3. Competitive Scenario
9.4.3.4. Regulatory Framework
9.4.3.5. Reimbursement Scenario
9.4.3.6. Japan Microbial API Market, 2018 - 2030 (USD Million)
9.4.4. China
9.4.4.1. Key Country Dynamics
9.4.4.2. Target Disease Prevalence
9.4.4.3. Competitive Scenario
9.4.4.4. Regulatory Framework
9.4.4.5. Reimbursement Scenario
9.4.4.6. China Microbial API Market, 2018 - 2030 (USD Million)
9.4.5. India
9.4.5.1. Key Country Dynamics
9.4.5.2. Target Disease Prevalence
9.4.5.3. Competitive Scenario
9.4.5.4. Regulatory Framework
9.4.5.5. Reimbursement Scenario
9.4.5.6. India Microbial API Market, 2018 - 2030 (USD Million)
9.4.6. South Korea
9.4.6.1. Key Country Dynamics
9.4.6.2. Target Disease Prevalence
9.4.6.3. Competitive Scenario
9.4.6.4. Regulatory Framework
9.4.6.5. Reimbursement Scenario
9.4.6.6. South Korea Microbial API Market, 2018 - 2030 (USD Million)
9.4.7. Australia
9.4.7.1. Key Country Dynamics
9.4.7.2. Target Disease Prevalence
9.4.7.3. Competitive Scenario
9.4.7.4. Regulatory Framework
9.4.7.5. Reimbursement Scenario
9.4.7.6. Australia Microbial API Market, 2018 - 2030 (USD Million)
9.4.8. Thailand
9.4.8.1. Key Country Dynamics
9.4.8.2. Target Disease Prevalence
9.4.8.3. Competitive Scenario
9.4.8.4. Regulatory Framework
9.4.8.5. Reimbursement Scenario
9.4.8.6. Thailand Microbial API Market, 2018 - 2030 (USD Million)
9.5. Latin America
9.5.1. SWOT Analysis
9.5.2. Latin America Microbial API Market, 2018 - 2030 (USD Million)
9.5.3. Brazil
9.5.3.1. Key Country Dynamics
9.5.3.2. Target Disease Prevalence
9.5.3.3. Competitive Scenario
9.5.3.4. Regulatory Framework
9.5.3.5. Reimbursement Scenario
9.5.3.6. Brazil Microbial API Market, 2018 - 2030 (USD Million)
9.5.4. Mexico
9.5.4.1. Key Country Dynamics
9.5.4.2. Target Disease Prevalence
9.5.4.3. Competitive Scenario
9.5.4.4. Regulatory Framework
9.5.4.5. Reimbursement Scenario
9.5.4.6. Mexico Microbial API Market, 2018 - 2030 (USD Million)
9.5.5. Argentina
9.5.5.1. Key Country Dynamics
9.5.5.2. Target Disease Prevalence
9.5.5.3. Competitive Scenario
9.5.5.4. Regulatory Framework
9.5.5.5. Reimbursement Scenario
9.5.5.6. Argentina Microbial API Market, 2018 - 2030 (USD Million)
9.6. MEA
9.6.1. SWOT Analysis
9.6.2. MEA Microbial API Market, 2018 - 2030 (USD Million)
9.6.3. South Africa
9.6.3.1. Key Country Dynamics
9.6.3.2. Target Disease Prevalence
9.6.3.3. Competitive Scenario
9.6.3.4. Regulatory Framework
9.6.3.5. Reimbursement Scenario
9.6.3.6. South Africa Microbial API Market, 2018 - 2030 (USD Million)
9.6.4. Saudi Arabia
9.6.4.1. Key Country Dynamics
9.6.4.2. Target Disease Prevalence
9.6.4.3. Competitive Scenario
9.6.4.4. Regulatory Framework
9.6.4.5. Reimbursement Scenario
9.6.4.6. Saudi Arabia Microbial API Market, 2018 - 2030 (USD Million)
9.6.5. UAE
9.6.5.1. Key Country Dynamics
9.6.5.2. Target Disease Prevalence
9.6.5.3. Competitive Scenario
9.6.5.4. Regulatory Framework
9.6.5.5. Reimbursement Scenario
9.6.5.6. UAE Microbial API Market, 2018 - 2030 (USD Million)
9.6.6. Kuwait
9.6.6.1. Key Country Dynamics
9.6.6.2. Target Disease Prevalence
9.6.6.3. Competitive Scenario
9.6.6.4. Regulatory Framework
9.6.6.5. Reimbursement Scenario
9.6.6.6. Kuwait Microbial API Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.2.1. New Product Launch
10.2.2. Partnerships
10.2.3. Acquisition
10.2.4. Collaboration
10.2.5. Funding
10.3. Key Company Market Share Analysis, 2022
10.4. Company Heat Map Analysis
10.5. Company Profiles
10.5.1. MERCK & CO., INC.
10.5.1.1. Company overview
10.5.1.2. Financial performance
10.5.1.3. Product benchmarking
10.5.1.4. Strategic initiatives
10.5.2. Topfond Pharmaceutical Co., Ltd.
10.5.2.1. Company overview
10.5.2.2. Financial performance
10.5.2.3. Product benchmarking
10.5.2.4. Strategic initiatives
10.5.3. DSM
10.5.3.1. Company overview
10.5.3.2. Financial performance
10.5.3.3. Product benchmarking
10.5.3.4. Strategic initiatives
10.5.4. CSPC Pharmaceutical Group Limited
10.5.4.1. Company overview
10.5.4.2. Financial performance
10.5.4.3. Product benchmarking
10.5.4.4. Strategic initiatives
10.5.5. KOLON LIFE SCIENCE
10.5.5.1. Company overview
10.5.5.2. Financial performance
10.5.5.3. Product benchmarking
10.5.5.4. Strategic initiatives
10.5.6. Shandong Lukang Pharmaceutical Co., Ltd.
10.5.6.1. Company overview
10.5.6.2. Financial performance
10.5.6.3. Product benchmarking
10.5.6.4. Strategic initiatives
10.5.7. Teva Pharmaceutical Industries Ltd.
10.5.7.1. Company overview
10.5.7.2. Financial performance
10.5.7.3. Product benchmarking
10.5.7.4. Strategic initiatives
10.5.8. Lonza
10.5.8.1. Company overview
10.5.8.2. Financial performance
10.5.8.3. Product benchmarking
10.5.8.4. Strategic initiatives

List of Tables
Table 1 List of abbreviations
Table 2 Global Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 3 Global Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 4 Global Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 5 Global Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 6 Global Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 7 Global Microbial API Market, by Region, 2018 - 2030 (USD Million)
Table 8 North America Microbial API Market, by Country, 2018 - 2030 (USD Million)
Table 9 North America Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 10 North America Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 11 North America Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 12 North America Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 13 North America Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 14 U.S. Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 15 U.S. Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 16 U.S. Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 17 U.S. Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 18 U.S. Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 19 Canada Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 20 Canada Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 21 Canada Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 22 Canada Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 23 Canada Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 24 Europe Microbial API Market, by Country, 2018 - 2030 (USD Million)
Table 25 Europe Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 26 Europe Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 27 Europe Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 28 Europe Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 29 Europe Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 30 Germany Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 31 Germany Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 32 Germany Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 33 Germany Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 34 Germany Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 35 UK Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 36 UK Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 37 UK Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 38 UK Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 39 UK Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 40 France Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 41 France Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 42 France Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 43 France Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 44 France Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 45 Italy Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 46 Italy Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 47 Italy Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 48 Italy Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 49 Italy Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 50 Spain Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 51 Spain Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 52 Spain Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 53 Spain Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 54 Spain Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 55 Denmark Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 56 Denmark Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 57 Denmark Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 58 Denmark Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 59 Denmark Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 60 Sweden Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 61 Sweden Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 62 Sweden Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 63 Sweden Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 64 Sweden Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 65 Norway Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 66 Norway Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 67 Norway Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 68 Norway Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 69 Norway Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 70 Asia Pacific Microbial API Market, by Country, 2018 - 2030 (USD Million)
Table 71 Asia Pacific Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 72 Asia Pacific Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 73 Asia Pacific Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 74 Asia Pacific Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 75 Asia Pacific Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 76 China Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 77 China Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 78 China Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 79 China Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 80 China Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 81 Japan Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 82 Japan Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 83 Japan Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 84 Japan Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 85 Japan Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 86 India Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 87 India Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 88 India Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 89 India Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 90 India Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 91 South Korea Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 92 South Korea Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 93 South Korea Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 94 South Korea Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 95 South Korea Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 96 Australia Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 97 Australia Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 98 Australia Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 99 Australia Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 100 Australia Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 101 Thailand Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 102 Thailand Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 103 Thailand Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 104 Thailand Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 105 Thailand Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 106 Latin America Microbial API Market, by Country, 2018 - 2030 (USD Million)
Table 107 Latin America Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 108 Latin America Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 109 Latin America Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 110 Latin America Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 111 Latin America Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 112 Brazil Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 113 Brazil Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 114 Brazil Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 115 Brazil Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 116 Brazil Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 117 Mexico Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 118 Mexico Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 119 Mexico Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 120 Mexico Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 121 Mexico Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 122 Argentina Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 123 Argentina Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 124 Argentina Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 125 Argentina Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 126 Argentina Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 127 Middle East & Africa Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 128 Middle East & Africa Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 129 Middle East & Africa Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 130 Middle East & Africa Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 131 Middle East & Africa Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 132 South Africa Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 133 South Africa Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 134 South Africa Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 135 South Africa Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 136 South Africa Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 137 Saudi Arabia Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 142 UAE Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 143 UAE Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 144 UAE Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 145 UAE Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 146 UAE Microbial API Market, by Molecule, 2018 - 2030 (USD Million)
Table 147 Kuwait Microbial API Market, by Host, 2018 - 2030 (USD Million)
Table 148 Kuwait Microbial API Market, by Type, 2018 - 2030 (USD Million)
Table 149 Kuwait Microbial API Market, by Site, 2018 - 2030 (USD Million)
Table 150 Kuwait Microbial API Market, by End-use, 2018 - 2030 (USD Million)
Table 151 Kuwait Microbial API Market, by Molecule, 2018 - 2030 (USD Million)

お買い物ガイド

よくある質問

この商品のレポートナンバー

0000036731

国内・海外の市場調査レポート販売

世界中の市場調査レポートを販売！当社に無いレポートもお探しします。